CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for ...

CRISPR Therapeutics CRSP and Intellia Therapeutics NTLA are leading developers of therapies that utilize the Nobel ...

Last month, a baby got the world’s first personalized gene-editing treatment. What will this mean for millions of others with ...

They also found that after the extra chromosome was removed, genes tied to nervous system development were more active and ...

The expansion of precision breeding and genome editing tools, such as CRISPR, is further accelerating market advancements. In 2024, the agricultural biotechnology market is witnessing significant ...

LLY's move to buy Verve ignites investor interest across gene-editing stocks like CRSP, NTLA and BEAM in a booming M&A year.

Repositioning genes awakens fetal hemoglobin to treat disease. CRISPR editing may change future gene therapy. Researchers ...

Eli Lilly has struck a deal to buy Crispr gene-editing start-up Verve Therapeutics for up to $1.3bn, the latest acquisition ...

CRISPR Therapeutics (NASDAQ:CRSP) operates within the biotechnology segment, which remains active across key indices like the ...

While some scientists argue that agricultural gene editing regulations are overly restrictive, a new paper from the ...

Back in 1900 the life expectancy of people with Down Syndrome was 9 years. In 1984, it was 28 years, today it's leveled off ...